Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Roche
Roche
Roche’s Vismodegib Meets Main Goal of Advanced Skin-Cancer Study
Bloomberg
Sat, 09/24/11 - 12:43 pm
vismodegib
Roche
basal cell carcinoma
skin cancer
Roche, Mylan Settle Patent Case Over Drug Xeloda
Bloomberg
Thu, 09/22/11 - 08:30 am
Mylan
Roche
patents
Xeloda
cancer
Regeneron Soars on Eye-Drug Rival Setback
TheStreet.com
Wed, 09/21/11 - 11:24 pm
Regeneron
Roche
Avastin
wet-AMD
age-related macular degeneration
What's Bad For Bisphosphonates Is Good For Emisphere
Seeking Alpha
Tue, 09/13/11 - 10:18 am
Emisphere
bisphosphonates
Amgen
Merck
Novartis
Roche
Sanofi
Roche Seeks FDA Approval for Skin Cancer Drug
Bloomberg
Mon, 09/12/11 - 09:58 am
FDA
Roche
skin cancer
vismodegib
Bone Drugs Need Label Changes on Use Duration, Panel Says
Bloomberg
Sat, 09/10/11 - 10:40 am
Warner Chilcott
Roche
Merck
Novartis
osteoporosis
bone growth
Actonel
Boniva
Reclast
Fosamax
GSK stops Tykerb-only arm in cancer trial
Fierce Pharma
Fri, 09/9/11 - 12:02 pm
GSK
Tykerb
Roche
Herceptin
breast cancer
Off-Label Avastin Use, Medicare And Saving Money
Pharmalot
Wed, 09/7/11 - 09:54 am
Medicare
off-label
Avastin
Roche
Genentech
age-related macular degeneration
Roche Signs First Alzheimer's Deal Of 2011 As Crucial Progress Awaited
Seeking Alpha
Wed, 09/7/11 - 09:34 am
Roche
Alzheimer's disease
Ranbaxy
Elan
JNJ
Eli Lilly
Pfizer
Roche to maintain lead in targeted drugs
Yahoo/Reuters
Wed, 08/31/11 - 12:55 pm
Roche
targeted therapeutics
Novartis
Pfizer
Off-Label Avastin Injections Linked To Blindness
Pharmalot
Wed, 08/31/11 - 09:31 am
off-label
blindness
Avastin
Genentech
Roche
Power outages, floods close offices of drugmakers
Yahoo/AP
Mon, 08/29/11 - 05:37 pm
weather
Hurricane Irene
JNJ
GSK
Bayer
Teva Pharmaceuticals
Cephalon
Roche
Bone drug tied to lower colon cancer risk
Yahoo/Reuters
Tue, 08/23/11 - 08:26 am
colon cancer
biophosphonates
Merck
Fosamax
Roche
Boniva
Novartis
Reclast
Actonel
Warner Chilcott
Roche CEO Schwan spotlights Roche's top three blockbuster hopefuls
Fierce Biotech
Mon, 08/22/11 - 01:16 pm
Roche
Severin Schwan
Metmab
lung cancer
lebrikizumab
Pertuzumab
asthma
breast cancer
Roche Rises After Good-Cholesterol Drug Shows Promise in Study
Bloomberg
Mon, 08/22/11 - 10:33 am
Roche
dalcetrapib
Roche Seeks Win on Heart Pill Where Pfizer Failed
Bloomberg
Fri, 08/19/11 - 09:07 am
Roche
Pfizer
dalcetrapib
heart disease
Roche, Daiichi Sankyo Win U.S. Approval on Drug to Treat Advanced Melanoma
Bloomberg
Wed, 08/17/11 - 12:03 pm
Zelboraf
Roche
melanoma
FDA
Daiichi Sankyo
Regeneron Says FDA Delays Eylea Drug for Blindness
Bloomberg
Wed, 08/17/11 - 08:27 am
Regeneron
FDA
blindness
Eylea
Lucentis
Roche
Roche licenses vemurafenib to Chugai
Pharmaceutical Business Review
Mon, 08/15/11 - 12:25 pm
Roche
vemurafenib
Chugai
melanoma
BRAF inhibitor
Roche/Array: 2 Shots Are Better Than 1
Seeking Alpha
Fri, 08/12/11 - 12:45 pm
Roche
Array Biopharma
ChK-1 inhibitors
cancer
Pages
« first
‹ previous
…
89
90
91
92
93
94
95
96
97
…
next ›
last »